Aquinox Pharma Raises $25 Million
Aquinox Pharmaceuticals Inc., a Vancouver-based small-molecule drug company focused on cancer and inflammatory disease, has raised US$25 million in Series B funding. Ventures West Capital led the round, and was joined by fellow return backers Johnson & Johnson Development Corporation, Baker Brothers Investments and BC Advantage Funds Ltd. New investor Pfizer Venture Investments also participated.
18 June 2010•2 mins read
